Highly Sensitive Thyroglobulin and Anti-thyroglobulin Antibody Measurement in DTC Management

Thyroglobulin (Tg) measurement remains the cornerstone of modern management of differentiated thyroid cancer (DTC), with clinical decisions on treatment and follow-up based on the results of such measurements. However, Tg measurement is a highly complex process with many pitfalls and interferences, most notably from anti-thyroglobulin antibodies (TgAb).

This session will review and discuss issues concerning analytical aspects of hsTg and TgAb measurement and issues related to the clinical consequences of these measurements.